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1616 The Journal of Thoracic and CardObjective: The purpose of this study was to evaluate the effect of lobectomy on
pulmonary function in patients with chronic obstructive pulmonary disease.
Methods: One hundred thirty-seven patients were analyzed; 49 had normal pulmo-
nary function tests, and 88 had chronic obstructive pulmonary disease. Different
functional parameter groups were identified: obstructive (forced expiratory volume
in 1 second [FEV1], forced expiratory volume in 1 second/forced vital capacity
[FEV1/FVC], and chronic obstructive pulmonary disease index), hyperinflation
(residual volume and functional residual capacity), and diffusion (transfer factor of
the lung for carbon monoxide). Also, the ratio between observed and predicted
postoperative FEV1 was calculated.
Results: In patients with preoperative FEV1 greater than 80% of predicted, postop-
erative FEV1/FVC slightly but not significantly decreased, and postoperative FEV1
significantly decreased. In patients with preoperative FEV1 less than 65%, postop-
erative FEV1 and FEV1/FVC significantly increased. In patients with preoperative
FEV1/FVC greater than 70%, postoperative FEV1 and FEV1/FVC significantly
decreased. In patients with preoperative FEV1/FVC less than 70%, postoperative
FEV1/FVC increased, and FEV1 remained unchanged. In patients with a chronic
obstructive pulmonary disease index greater than 1.5, postoperative FEV1 and
FEV1/FVC significantly decreased, whereas in patients with a chronic obstructive
pulmonary disease index less than 1.5, postoperative FEV1/FVC significantly in-
creased and FEV1 remained unchanged. In patients with residual volume and
functional residual capacity greater than 115% and transfer factor of the lung for
carbon monoxide less than 80% of predicted, postoperative FEV1 diminished less
(not significant) compared with patients who had residual volume and functional
residual capacity less than 115% (P  .0001). Observed postoperative/predicted
postoperative FEV1 was higher if FEV1/FVC was less than 55% (1.46), if FEV1 was
less than 80% of predicted (1.21), or if the chronic obstructive pulmonary disease
index was less than 1.5 (1.17).
Conclusions: Patients with mild to severe chronic obstructive pulmonary disease
could have a better late preservation of pulmonary function after lobectomy than
healthy patients.
Lung cancer remains an important cause of death among smokers, and thiscondition is often associated with chronic obstructive pulmonary disease(COPD). Surgical resection offers the best chance for curing lung cancer, and
lobectomy is the most frequent operation performed. Postoperative respiratory
failure is a widely known complication that limits parenchymal resection in patients
with COPD; exclusion criteria have been adopted to evaluate these patients, and
iovascular Surgery ● December 2005
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TSmost of them outline the importance of preoperative forced
expiratory volume in 1 second (FEV1), FEV1/forced vital
capacity (FVC), and transfer factor of the lung for carbon
monoxide (TLCO). The 6-minute walking test, Master test,
maximum oxygen consumption per unit time test, and pre-
diction of postoperative FEV1 by different formulas are also
used to evaluate postoperative risk.1 More recently, lung
volume reduction surgery and recent reports on COPD
patients operated on for lung cancer have revised the lung
function evaluation and predictors for COPD patients who
are candidates for lung resection.2-7 Unfortunately, most of
these reports on lobectomy in patients with airway obstruc-
tion reviewed a limited number of cases, and the selection of
operable patients remains a great challenge.2-7 The goal of
this study was to evaluate the effect of lobectomy on pul-
monary function in COPD patients.
Materials and Methods
This was a retrospective, multicenter national study. Data from 7
Italian hospitals with thoracic surgery experience (including lung
transplantation, lung volume reduction surgery, or both) were
collected. All patients with at least 1 preoperative and 1 postop-
erative pulmonary function evaluation who underwent lobectomy
for lung cancer from March 1997 to March 2003 were considered;
usually no more than a 6-month period was analyzed for each
center. Postoperative pulmonary function tests (PFTs) were per-
formed not earlier than the third postoperative month and not later
than the 15th month. Patients who received any adjuvant or neo-
adjuvant therapy were not considered eligible for this study. One
hundred thirty-seven patients met the criteria (35 women and 102
men); 49 had normal static and dynamic pulmonary function,
according to European Respiratory Society 1993, whereas 88 had
COPD ranging from grade 1 to 3 according to Global Initiative on
Obstructive Lung Disease guidelines. Hyperinflation was consid-
ered if residual volume (RV) and functional residual capacity
(FRC) were greater than 115% of predicted and vital capacity was
in the normal limit, and impairment of gas transfer was defined as
TLCO less than 80% of predicted. PFTs were performed in different
laboratories by using the European Respiratory Society 1993 pre-
dicting values. All tests were performed with the same methods,
and static volumes were measured by the nitrogen washout
method. Patients were evaluated by radiograph and computed
Abbreviations and Acronyms
COPD  chronic obstructive pulmonary disease
FEV1  forced expiratory volume in 1 second
FEV1(%)  FEV1 percentage of predicted
FRC  functional residual capacity
FVC  forced vital capacity
PFT  pulmonary function test
RV  residual volume
TLCO  transfer factor of the lung for carbon
monoxidetomographic scan to stage the tumor, to ascertain the presence of
The Journal of Thoracica flattening diaphragm, and to distinguish bullous from nonbullous
emphysema.
Ninety-two patients underwent upper lobectomy, 37 underwent
lower lobectomy, and 8 underwent middle lobectomy; 17% of
these patients had bullous emphysema, and 32% had diaphrag-
matic flattening. Thirty-one had squamous cell cancer, 72 had
adenocarcinoma, 5 had small cell lung cancers, and 4 had carci-
noid tumors. In 25 patients, histologic results were not available or
were uncertain.
In all patients, the observed postoperative FEV1 was compared
with the predicted postoperative FEV1 by the observed postoperative/
predicted postoperative FEV1 ratio. The predicted postoperative
FEV1 value was calculated with the following equation:
Predicted postperative FEV1 Preoperative FEV1
 (No. of segments remaining ⁄
Total no. of segments)
The COPD index was calculated according to Korst and associ-
ates5 to evaluate the severity and purity of obstructive airway
disease; the preoperative FEV1 (percentage of predicted in decimal
form; FEV1%) was added to the preoperative ratio of FEV1 to
FVC. Patients with the lowest COPD index are those with the most
severe airway obstruction. Patients with a COPD index greater
than 1.5 do not have obstructive diseases.
The mean age of COPD patients was 68  15 years, and the
mean age of non-COPD patients was 66 13 years (mean SD).
FEV1 ranged from 980 mL (34% of predicted) to 4050 mL (115%
of predicted) in the entire study population. Preoperative func-
tional data in healthy and COPD patients are shown in Table 1.
Statistical analysis included the paired t test for comparison of
preoperative and postoperative mean values, because the patients
were observed before and after a single treatment. Smith’s statistical
software package version 2.5, 2001 (by G. Smith, Claremont, Calif)
was used for all analyses. Statistical methods included multiple com-
parisons of interrelated parameters, and this may cause problems with
determining the appropriate significance level. To overcome this
problem, we computed the number of comparisons for each category
TABLE 1. Study population
Variable
COPD
(88 patients)
Normal
(49 patients) P value
FVC% 96 17 102 16 P  .04
FEV1(%) 63  8 98  15 P  .00001
FEV1/FVC 58  8 76  5 P  .00001
COPD index 1.28 0.26 1.71 0.23 P  .00001
RV% 117 26 103  27 P  .001
TLC% 100 13 99 13 P  .6
TLCO% 69  17 85  22 P  .00001
PaO2-pre (mm Hg) 80  9 84  8 P  .01
PaCO2-post (mm Hg) 36  5 39  3 P  .002
COPD, Chronic obstructive pulmonary disease; FVC, forced vital capacity;
FEV1(%), forced expiratory volume in 1 second percentage of predicted;
RV, residual volume; TLC, total lung capacity; TLCO, transfer factor of the
lung for carbon monoxide.group (each table) and decreased the significance level by an appro-
and Cardiovascular Surgery ● Volume 130, Number 6 1617
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significance level was decreased by 20-fold (from .05 to .002), and for
4  2 comparisons, the significance level was decreased by 10-fold
(from .05 to .005).
Results
Flow volume and blood gas analyses were available in all
patients, dynamic and static lung volumes were available in
108 patients, and carbon monoxide diffusion capacity was
available in 89 patients. Preoperative chest radiographs and
computed tomographic scans were examined in most COPD
Figure 1. Observed postoperative/predicted postoperative FEV
TABLE 2. FEV1 group data
Variable FEV1 <65%
FEV1 >65%
<80% FEV1 >80% FEV1 <80%
FEV1-pre (%) 56  7 69  3 98  15 63 8
FEV1-post (%) 64  11 65 17 78 16 65 14
P  .0004 P  .17 P  .0001 P  .29
FEV1/FVC-pre 55  10 65 10 70 8 59  11
FEV1/FVC-
post
64  11 66 16 66 10 65 14
P  .0004 P  .7 P  .06 P  .004
RV-pre (%) 117 27 114 22 108 30 116 24
RV-post (%) 94 18 91 24 84 27 93 20
P  .0003 P  .0003 P  .0003 P  .00001
PaO2-pre
(mm Hg)
83  9 79  8 84  8 80  9
PaO2-post
(mm Hg)
79  9 78  8 83  9 79  9
P  .7 P  .6 P  .7 P  .5
FEV1, Forced expiratory volume in 1 second; FVC, forced vital capacity; RV,
residual volume.ratio according to FEV1(%).
1618 The Journal of Thoracic and Cardiovascular Surgery ● Decpatients to consider diaphragmatic flattening and bullous
emphysema. No postoperative differences were observed
with regard to the lobectomy area because upper, lower, or
middle lobe resection did not influence the postoperative
FEV1 or FEV1/FVC change.
Patients were divided into different groups to character-
ize the grade of airway obstruction, the grade of hyperin-
flation, and the grade of carbon monoxide diffusion capac-
ity. Changes of functional variables before and after
operation were then analyzed.
Obstructive Parameters (FEV1[%], FEV1/FVC, and
COPD Index)
We analyzed patients by considering 3 airway obstruction
parameters: FEV1(%), FEV1/FVC, and COPD index. For
FEV1(%), FEV1 group 1 included 65 patients with an FEV1
of 80% or more; FEV1 group 2 included 72 patients with
FEV1 less than 80%; FEV1 subgroup 2a included 37 pa-
tients with FEV1 less than 65%; and FEV subgroup 2b
included 35 patients with FEV1 between 65% and 79%.
Among patients in FEV1 group 1, the postoperative FEV1/
FVC slightly but not significantly decreased, whereas FEV1
significantly decreased and PaO2 remained unchanged. In
FEV1 group 2, FEV1/FVC significantly increased, and
FEV1 and PaO2 remained mostly unchanged. In FEV1 sub-
group 2a, FEV1/FVC and FEV1 significantly increased,
whereas in FEV1 subgroup 2b, both FEV1/FVC and FEV1
remained unchanged. RV significantly decreased on post-
operative follow-up in all groups examined (Table 2). The
observed postoperative/predicted postoperative ratio for
TABLE 3. FEV1/FVC group data
Variable
FEV1/FVC
<55%
FEV1/FVC
>55 <70%
FEV1/FVC
>70%
FEV1/FVC
<70%
FEV1-pre (%) 60  13 76 14 96 21 70 67
FEV1-post (%) 65  12 69 17 78 16 67 16
P  .1 P  .01 P  .00007 P  .6
FEV1/FVC-pre 48  15 63 4 76 5 58 8
FEV1/FVC-post 67  16 64 14 66 10 65 13
P  .00002 P  .6 P  .00001 P  .0003
RV-pre (%) 123 25 114 26 103 27 117 26
RV-post (%) 95 18 90 23 84 27 93 20
P  .00009 P  .000001 P  .0007 P  .000001
PaO2-pre
(mm Hg)
83  9 79 8 84 8 80 9
PaO2-post
(mm Hg)
79  9 78 8 83 9 79 9
P  .09 P  .5 P  .5 P  .4
FEV1, Forced expiratory volume in 1 second; FVC, forced vital capacity; RV,
residual volume.1FEV1 in FEV1 group 1 was lower (0.91  SD 0.1) than in
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SD 0.09; Figure 1).
For FEV1/FVC, FEV1/FVC group 1 included 49 patients
with FEV1/FVC greater than 70%; FEV1/FVC group 2
included 88 patients with FEV1/FVC less than 70%; FEV1/
FVC subgroup 2a included 29 patients with FEV1/FVC less
than 55%; and FEV1/FVC subgroup 2b included 59 patients
with FEV1/FVC between 55% and 69%. In FEV1/FVC
group 1, FEV1 and FEV1/FVC significantly decreased,
whereas PaO2 remained unchanged; in FEV1/FVC group 2,
FEV1 and PaO2 remained mostly unchanged, whereas FEV1/
FVC significantly increased. It is interesting to note that in
FEV1/FVC subgroup 2a, FEV1 slightly increased (not sig-
Figure 2. Observed postoperative/predicted postoperative FEV1
ratio according to TI. TI, FEV1/FVC.
TABLE 4. COPD index group data
Variable COPD index <1.5 COPD index >1.5
FEV1-pre (%) 65  10 99 17
FEV1-post (%) 66  15 77 16
P  .6 P  .000001
FEV1/FVC-pre 58  10 72 8
FEV1/FVC-post 65  13 65.9 10
P  .0001 P  .001
RV-pre (%) 116 23 109 37
RV-post (%) 93 20 84 27
P  .000001 P  .0002
PaO2-pre (mm Hg) 79.9 9 85  8
PaO2-post (mm Hg) 79.5 9 83  9
P  .7 P  .2
COPD, Chronic obstructive pulmonary disease; FEV , forced expiratory1
volume in 1 second; FVC, forced vital capacity; RV, residual volume.
The Journal of Thoracicnificant) and FEV1/FVC significantly increased, but in
FEV1/FVC subgroup 2b, FEV1 decreased and FEV1/FVC
remained unchanged (Table 3). The observed postoperative/
predicted postoperative ratio for FEV1 in FEV1/FVC sub-
group 2a was significantly higher (1.46  SD 0.16) than in
FEV1/FVC subgroup 2b (1  SD 0.09) and FEV1/FVC
group 1 (0.95  SD 0.09; Figure 2).
COPD index group 1 included 52 patients with an index
greater than 1.5, and COPD index group 2 included 85 patients
with an index less than 1.5. In COPD group 1, FEV1/FVC and
Figure 3. Observed postoperative/predicted postoperative FEV1
ratio according to COPD index.
TABLE 5. RV group data
Variable RV <115% RV >115%
FEV1-pre (%) 89  21 73.8  19
FEV1-post (%) 79  17 67 14
P  .007 P  .06
FEV1/FVC-pre 69  12 59 10
FEV1/FVC-post 68.9 10 60 11
P  .1 P  .06
RV-pre (%) 91 16 133  22
RV-post (%) 78 22 104  18
P  .0006 P  .00001
Observed postop/predicted
postop FEV1
1.02 0.084 1.08 0.091
PaO2-pre (mm Hg) 84  9 81  10
PaO2-post (mm Hg) 80  8 81  9
P  .06 P  .1
RV, Residual volume; FEV , forced expiratory volume in 1 second; FVC,1
forced vital capacity.
and Cardiovascular Surgery ● Volume 130, Number 6 1619
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FEV1/FVC significantly increased, and FEV1 remained un-
changed (Table 4). The observed postoperative/predicted post-
operative ratio for FEV1 in group 2 (1.17  SD 0.06) was
higher than in group 1 (0.91  SD 0.1; Figure 3).
Hyperinflation Parameters (RV and FRC)
RV group 1 included 53 patients with RV greater than
115%, and RV group 2 included 55 patients with RV less
than 115%. In RV group 1, FEV1 slightly (P  .06) de-
creased, and FEV1/FVC remained unchanged; in RV group
2, FEV1 significantly decreased, and FEV1/FVC remained
unchanged (Table 5).
FRC group 1 included 55 patients with FRC greater than
115%, and FRC group 2 included 53 patients with FRC less
than 115%. In FRC group 1, FEV1 and FEV1/FVC re-
mained statistically unchanged, whereas in FRC group 2,
FEV1 decreased, and FEV1/FVC remained unchanged
(Table 6).
Alveolar Diffusion Parameter (TLCO)
TLCO group 1 included 35 patients with a TLCO of 80% or
more, and TLCO group 2 included 54 patients with a TLCO
less than 80%. In TLCO group 1, FEV1 significantly de-
creased, whereas FEV1/FVC did not change; in TLCO group
2, FEV1 decreased, and FEV1/FVC increased, but these
differences were not significant (Table 7).
Discussion
Our results suggest that pulmonary function after lobectomy
TABLE 6. FRC group data
Variable FRC <115% FRC >115%
FEV1-pre (%) 87  20 79  24
FEV1-post (%) 74  17 72  16
P  .0005 P  .07
FEV1/FVC-pre 70  12 60  11
FEV1/FVC-post 68  11 61  11
P  .3 P  .6
RV-pre (%) 88.9 14 119 4
RV-post (%) 76 22 103 14
P  .0004 P  .00001
Observed postop/predicted
postop FEV1
1.03 0.089 1.04 0.082
PaO2-pre (mm Hg) 83  9 81  9
PaO2-post (mm Hg) 80  10 82  10
P  .1 P  .5
FRC, Functional residual capacity; FEV1, forced expiratory volume in 1
second; FVC, forced vital capacity; RV, residual volume.improves—or at least diminishes less—in COPD patients as
1620 The Journal of Thoracic and Cardiovascular Surgery ● Deccompared with non-COPD patients and that this phenome-
non is more evident in patients with more severe airway
obstruction and hyperinflation. In particular, some of the
preoperative functional parameters seem to be good predic-
tors of late postoperative function improvement (or minimal
change). FEV1/FVC improves if preoperative FEV1 is less
than 65% of predicted, if preoperative FEV1/FVC is less
than 55%, or if the COPD index is less than 1.5, whereas
FEV1/FVC worsens if the preoperative FEV1/FVC is more
than 70% and the COPD index is more than 1.5. FEV1
improves only if the preoperative FEV1 is less than 65%; it
always worsens when airway flow indexes, diffusion capac-
ity, and RV or FRC are in the normal range. Neither
obstruction parameters (FEV1 and FEV1/FVC) nor diffu-
sion capacity provides information on postoperative RV
changes, because this index always worsens after operation
and seems unrelated to these indexes. No change was ob-
served before and after operation regarding oxygen ex-
change, and these data are unrelated to the preoperative
functional data. It is interesting to note that the observed
postoperative FEV1 is better than the predicted postopera-
tive FEV1 if FEV1/FVC is less than 70%, if FEV1 is less
than 80% of predicted, or if the COPD index is less than 1.5.
TLCO and RV do not influence these variations. An impor-
tant and practical consideration is that the predicted post-
operative FEV1 underestimates the observed postoperative
FEV1 by approximately 45% if the preoperative FEV1/FVC
is less than 55% and by approximately 20% if the preoper-
ative FEV1 is less than 80% of predicted.
Preoperative evaluation for lung resection in lung carci-
noma has been well studied, and many reports have been
published to evaluate the early and late operative risk for
TABLE 7. TLCO group data
Variable DLCO<80% DLCO>80%
FEV1-pre (%) 68  15 96  20
FEV1-post (%) 63  14 83  15
P  .07 P  .003
FEV1/FVC-pre 58  12 70  9
FEV1/FVC-post 60  13 69  8
P  .4 P  .6
Observed postop/predicted
postop FEV1
1.07 0.1 1.02  0.08
PaO2-pre (mm Hg) 78  8 84  8
PaO2-post (mm Hg) 79  9 81  9
P  .5 P  .1
TLCO, Transfer factor of the lung for carbon monoxide; DLCO, carbon
monoxide diffusion in the lung; FEV1, forced expiratory volume in 1 second;
FVC, forced vital capacity.patients with obstructive airway diseases.8-11 Advances in an-
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in some patients, but respiratory impairment in the long term
remains a problem. Although many PFTs and exercise tests
have been used to evaluate risk among these patients, obstruc-
tive indexes such as FEV1 and FEV1/FVC are still the most
used criteria to exclude these patients from surgery. In general
practice, a preoperative FEV1 less than 1.5 L or 60% of
predicted or a predicted postoperative FEV1 less than 800 mL
or 40% of predicted is considered a high risk for lobectomy.1
Lung volume reduction surgery has demonstrated that lung
function and dyspnea can improve after removal of portions of
the lung parenchyma in patients with emphysema. Pulmonary
nodule resection and lung volume reduction are feasible and
are associated with minimal morbidity and significant im-
provement in pulmonary function.12-17
These data suggest that limited parenchymal resection, as
well as lobectomy, might be beneficial for preserving lung
function in patients with COPD. Previous investigators have
demonstrated the feasibility of limited resection in patients
with respiratory impairment.18-21 Errett and colleagues21
noted little difference in postoperative outcome in individuals
with moderate airflow obstruction (mean FEV1 of 1.56 L);
Miller and Hatcher19 noted little perioperative difficulty in
individuals with severe airflow obstruction (FEV1 less than
1.0 L) who underwent limited resection. More recently, it
has been reported that pulmonary function might remain
unchanged or even improve after lobectomy in COPD pa-
tients.2-5 Korst and colleagues5 reported that the mean
change in FEV1 after lobectomy was3.7% among patients
with a preoperative FEV1 of less than or equal to 60% of
predicted and was 15.7% for patients with a mean preop-
erative FEV1 of 69% of predicted. Sekine and associates2
documented that the postoperative ventilatory function in
COPD patients who had lower or middle/lower lobectomies
was better preserved than predicted.
The most important consideration from our study, as well
as from other similar studies,2-5 is that some patients will
have improved obstructive indexes after lobectomy: the
increase of FEV1/FVC means that airway caliber or elastic
recoil improves after resection. Our patients were identi-
fied retrospectively; therefore, we cannot know the pre-
cise nature of COPD and of the lung tissue resected (apart
from the presence of bullae in a small group), but the
consistent number of our sample implies that these results
are not attributable to lung volume reduction surgery.
Nevertheless, we can speculate that the mechanism of
this airway improvement could be the relief of hyperin-
flation and/or chest wall mechanics, although this im-
provement should not be related to emphysematous
lungs. Resection of a dead space in case of local pulmo-
nary artery involvement could be another way to explain
functional amelioration in some cases.
The Journal of ThoracicThis study has several limitations. We analyzed only
patients who had been discharged from the hospital, so we
did not consider early postoperative mortality or early func-
tional impairment. Furthermore, this was a retrospective
study limited to the involvement of 7 different hospitals and
selection of patients from different periods. Patients with
available postoperative PFTs over a limited period (from the
3rd to 15th postoperative months) and in a consecutive
temporal selection were involved. Patients first referred to
the respiratory specialist always performed postoperative
PFTs, but patients referred to a surgeon usually did not
perform postoperative PFTs. Therefore, the selection crite-
ria are related to the specialist who first visited the patient,
and this was usually related to the practitioner who ad-
dressed the patient for further evaluation of a pulmonary
lesion.
In conclusion, patients with mild to severe COPD could
present a better late preservation of pulmonary function
after lobectomy compared with healthy patients. This min-
imal deterioration or improvement of airway function seems
to be related to preoperative obstructive indexes.
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